These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 1710566)
21. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides. Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521 [TBL] [Abstract][Full Text] [Related]
22. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules. Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479 [TBL] [Abstract][Full Text] [Related]
23. Analysis of specificity for antigen, Mls, and allogenic MHC by transfer of T-cell receptor alpha- and beta-chain genes. Kaye J; Hedrick SM Nature; 1988 Dec; 336(6199):580-3. PubMed ID: 2849059 [TBL] [Abstract][Full Text] [Related]
24. T cell recognition of allopeptides in context of syngeneic MHC. Liu Z; Braunstein NS; Suciu-Foca N J Immunol; 1992 Jan; 148(1):35-40. PubMed ID: 1530797 [TBL] [Abstract][Full Text] [Related]
25. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589 [TBL] [Abstract][Full Text] [Related]
26. Specificity of human T lymphocytes expressing a gamma/delta T cell antigen receptor. Recognition of a polymorphic determinant of HLA class I molecules by a gamma/delta clone. Ciccone E; Viale O; Pende D; Malnati M; Battista Ferrara G; Barocci S; Moretta A; Moretta L Eur J Immunol; 1989 Jul; 19(7):1267-71. PubMed ID: 2527158 [TBL] [Abstract][Full Text] [Related]
27. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses. Lechler RI; Heaton T; Barber L; Bal V; Batchelor JR; Lombardi G Immunol Lett; 1992 Sep; 34(1):63-9. PubMed ID: 1478706 [TBL] [Abstract][Full Text] [Related]
28. Possible T4-HLA class II interaction as an essential event in antigen-specific helper T lymphocyte-dependent B cell activation. Fischer A; Sterkers G; Charron D; Durandy A Eur J Immunol; 1986 Sep; 16(9):1111-6. PubMed ID: 2944748 [TBL] [Abstract][Full Text] [Related]
29. In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340. Ulaeto D; Wallace L; Morgan A; Morein B; Rickinson AB Eur J Immunol; 1988 Nov; 18(11):1689-97. PubMed ID: 2904885 [TBL] [Abstract][Full Text] [Related]
30. T cell receptor recognition of MHC class II alloantigens is highly cell type dependent. Katz JF; Sant AJ J Immunol; 1994 Feb; 152(4):1629-40. PubMed ID: 7907104 [TBL] [Abstract][Full Text] [Related]
31. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2. López D; Barber DF; Villadangos JA; López de Castro JA J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078 [TBL] [Abstract][Full Text] [Related]
32. Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II molecules. Jones CM; Lake RA; Lamb JR; Faith A Eur J Immunol; 1994 May; 24(5):1137-42. PubMed ID: 7514130 [TBL] [Abstract][Full Text] [Related]
33. HLA class I and II molecules present influenza virus antigens with different kinetics. Kuijpers KC; van Kemenade FJ; Hooibrink B; Neefjes JJ; Lucas CJ; van Lier RA; Miedema F Eur J Immunol; 1992 Sep; 22(9):2339-45. PubMed ID: 1516624 [TBL] [Abstract][Full Text] [Related]
34. T cell receptor gene segment utilization by HLA-DR1-alloreactive T cell clones. Geiger MJ; Gorski J; Eckels DD J Immunol; 1991 Oct; 147(7):2082-7. PubMed ID: 1833450 [TBL] [Abstract][Full Text] [Related]
35. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts. Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281 [TBL] [Abstract][Full Text] [Related]
36. HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing. de Koster HS; van Rood JJ; Termijtelen A Eur J Immunol; 1992 Jun; 22(6):1531-9. PubMed ID: 1376262 [TBL] [Abstract][Full Text] [Related]
37. Peptide-induced T cell clones: specificity, MHC restriction, proliferation and cytokine pattern as a function of different stimulations. Pichler WJ; Brander C; Mauri D; Frutig K; Wyss-Coray T Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):141-53; discussion 153-4. PubMed ID: 7873053 [TBL] [Abstract][Full Text] [Related]
38. Analysis of T hybridomas prepared from a T cell clone with three specificities. Recognition of self + X and allo-H-2 determinants segregates from recognition of Mlsa determinants. Webb SR; Okamoto A; Sprent J J Immunol; 1988 Sep; 141(6):1828-34. PubMed ID: 2459192 [TBL] [Abstract][Full Text] [Related]
39. Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells. Ceppellini R; Frumento G; Ferrara GB; Tosi R; Chersi A; Pernis B Nature; 1989 Jun; 339(6223):392-4. PubMed ID: 2786148 [TBL] [Abstract][Full Text] [Related]
40. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis. Strang G; Rickinson AB Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]